A patient on amphotericin B develops hypokalemia of 2,3 meq/l. K+ supplementation required:(AIIMS Nov 2013, Nov 2012)
## **Core Concept**
Amphotericin B is an antifungal medication known to cause **hypokalemia** (low potassium levels) and **magnesium wasting** as side effects. This occurs because amphotericin B increases the permeability of the renal tubules, leading to excessive loss of potassium and magnesium ions.
## **Why the Correct Answer is Right**
The correct approach to managing hypokalemia, especially in the context of amphotericin B therapy, involves not only replenishing potassium but also considering the severity of the deficiency and the ongoing losses. For a potassium level of 2.3 meq/l, which is significantly low, **aggressive potassium replacement** is often required. The standard potassium replacement guidelines suggest that for severe hypokalemia (<3.0 mEq/L), 20-40 mEq of potassium can be given per liter of IV fluid, but this can vary based on the patient's cardiac status, renal function, and the severity of the deficit.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it suggests a very low dose of potassium replacement, which would be insufficient for correcting a severe deficit like 2.3 meq/l.
- **Option B:** Similarly, this option might not provide enough potassium to effectively manage the severe hypokalemia caused by amphotericin B.
- **Option D:** While this option suggests a higher dose, without specific context on concentration or volume, it's hard to judge its adequacy directly, but typically, potassium repletion often requires higher doses especially in the setting of ongoing losses.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **amphotericin B-induced hypokalemia** can be challenging to manage due to ongoing renal losses. Therefore, not only does the serum potassium level need to be monitored closely, but also, potassium supplementation often needs to be **aggressive** and **proactive**. Additionally, it's crucial to monitor the patient's **ECG** and renal function during potassium repletion.
## **Correct Answer:** . 40 mEq/L of IV potassium chloride.